Literature DB >> 15226418

N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.

Philippe Coulombe1, Geneviève Rodier, Eric Bonneil, Pierre Thibault, Sylvain Meloche.   

Abstract

Extracellular signal-regulated kinase 3 (ERK3) is an unstable mitogen-activated protein kinase homologue that is constitutively degraded by the ubiquitin-proteasome pathway in proliferating cells. Here we show that a lysineless mutant of ERK3 is still ubiquitinated in vivo and requires a functional ubiquitin conjugation pathway for its degradation. Addition of N-terminal sequence tags of increasing size stabilizes ERK3 by preventing its ubiquitination. Importantly, we identified a fusion peptide between the N-terminal methionine of ERK3 and the C-terminal glycine of ubiquitin in vivo by tandem mass spectrometry analysis. These findings demonstrate that ERK3 is conjugated to ubiquitin via its free NH(2) terminus. We found that large N-terminal tags also stabilize the expression of the cell cycle inhibitor p21 but not that of substrates ubiquitinated on internal lysine residues. Consistent with this observation, lysineless p21 is ubiquitinated and degraded in a ubiquitin-dependent manner in intact cells. Our results suggests that N-terminal ubiquitination is a more prevalent modification than originally recognized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226418      PMCID: PMC434260          DOI: 10.1128/MCB.24.14.6140-6150.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 2.  Protein regulation by monoubiquitin.

Authors:  L Hicke
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 3.  A proteasome howdunit: the case of the missing signal.

Authors:  R Verma; R J Deshaies
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

4.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

Authors:  G Rodier; A Montagnoli; L Di Marcotullio; P Coulombe; G F Draetta; M Pagano; S Meloche
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

6.  alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.

Authors:  G K Tofaris; R Layfield; M G Spillantini
Journal:  FEBS Lett       Date:  2001-11-30       Impact factor: 4.124

7.  Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.

Authors:  D Rousseau; D Cannella; J Boulaire; P Fitzgerald; A Fotedar; R Fotedar
Journal:  Oncogene       Date:  1999-07-29       Impact factor: 9.867

8.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.

Authors:  R J Sheaff; J D Singer; J Swanger; M Smitherman; J M Roberts; B E Clurman
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

9.  Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.

Authors:  C Cayrol; B Ducommun
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

10.  Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.

Authors:  M J Servant; P Coulombe; B Turgeon; S Meloche
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

View more
  55 in total

1.  Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.

Authors:  Gustavo Martínez-Noël; Jeffrey T Galligan; Mathew E Sowa; Verena Arndt; Thomas M Overton; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.

Authors:  Engin Ozkan; Hongtao Yu; Johann Deisenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 3.  Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics.

Authors:  Donald S Kirkpatrick; Carilee Denison; Steven P Gygi
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

4.  APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.

Authors:  Virginia Amador; Sheng Ge; Patricia G Santamaría; Daniele Guardavaccaro; Michele Pagano
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

5.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

6.  hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.

Authors:  S C Gehen; R J Staversky; R A Bambara; P C Keng; M A O'Reilly
Journal:  Oncogene       Date:  2008-03-10       Impact factor: 9.867

7.  NF-kappaB dictates the degradation pathway of IkappaBalpha.

Authors:  Erika Mathes; Ellen L O'Dea; Alexander Hoffmann; Gourisankar Ghosh
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

8.  Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A.

Authors:  Hongyun Li; Koji Okamoto; Melissa J Peart; Carol Prives
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

9.  A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs.

Authors:  Jingping Xie; Chunxia Wang; John Virostko; H Charles Manning; Wellington Pham; Joshua Bauer; John C Gore
Journal:  Chembiochem       Date:  2013-07-24       Impact factor: 3.164

10.  Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.

Authors:  Ole-Morten Seternes; Theresa Mikalsen; Bjarne Johansen; Espen Michaelsen; Chris G Armstrong; Nick A Morrice; Benjamin Turgeon; Sylvain Meloche; Ugo Moens; Stephen M Keyse
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.